SCHEMBL6448285

SCHEMBL6448285

CCCCCNc1cc(C)nc(Oc2c(C)cc(Cl)cc2C)c1C

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 2/20 0.50
NR4A2 P43354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1030532 0.90 CRHR1 (0.62) CRHR1
SCHEMBL8339674 0.86 CRHR1 (0.55) CRHR1
SCHEMBL5843980 0.78 CRHR1 (0.42) CRHR1
SCHEMBL5600147 0.78 CRHR1 (0.81) CRHR1
SCHEMBL5875479 0.75 CRHR1 (0.43) CRHR1
SCHEMBL5843102 0.75 CRHR1 (0.69) CRHR1
SCHEMBL6094145 0.74 CRHR1 (0.61) CRHR1
SCHEMBL5843479 0.74 CRHR1 (0.70) CRHR1
SCHEMBL16606729 0.74 CRHR1 (0.46) CRHR1
SCHEMBL5843501 0.73 CRHR1 (0.59) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209250-A1 Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists PFIZER INC 2005-09-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209250-A1 Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists CRH, MC2R, CRHR2 CRHR1 5/4885NR4A2 1262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.